SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " body " 1,733 found 🔀 AI-powered Shuffle
Scientists reveal why walking gets so much harder with age
As we age, the body appears to sacrifice walking efficiency in exchange for stability. Older adults stiffen the ankle more with each step, which may help prevent falls but also forces the muscles to work harder while producing less forward motion. This leads to shorter strides, slower walking, and faster fatigue. Exercises targeting balance, coordination, and lower-leg strength could help preserve mobility.
Researchers Find That Waist Size Is a Powerful Indicator of Health Risks
Measuring waist size may be one of the simplest and most effective ways to detect obesity-related health risks, according to a study by Rutgers Health researchers. The study, published in JAMA Network Open, found that combining body mass index (BMI) with waist circumference, or using waist circumference alone, performed as well as a newly proposed obesity definition that incorporates multiple body measurements.
Massive Trump merchandise store goes out of business - because nobody is buying anything
‘We’re not busy anymore,’ one employee of the Trump store admitted
Courtney Love reveals secret health crisis that nearly killed her: 'My body just exploded'
Courtney Love shared that her body "just exploded" during a secret health crisis that left her near death, losing all her hair and dropping to 100 pounds.
New obesity definitions reveal ill health more accurately than body mass index
Traditionally, obesity has been classified primarily using BMI, a measure of weight relative to height that provides limited information about whether excess fat is actually affecting a person's health. ...
Four science-backed ways to tell if your dog trusts you
Dogs often make their feelings known through body language
COVID-19 awakens dormant viruses — and one is linked to long COVID
COVID-19 can reactivate dormant viruses hiding in the body, including Epstein-Barr, cytomegalovirus, and several herpes viruses. One poorly understood viral family was strongly associated with long COVID and lasting disability, offering a potentially important clue to why some patients struggle to recover.
Scientists detect a surprising shift in human blood as atmospheric CO2 rises
Rising carbon dioxide in the atmosphere may be leaving a measurable imprint inside the human body. Researchers analyzing more than two decades of U.S. health data found that blood bicarbonate levels have climbed about 7% since 1999, while calcium and phosphorus have declined—changes that closely track increasing atmospheric CO2.
T-Mobile is giving away the Apple iPhone 17 for free this weekend
Samsung and Google are getting all the attention right now, but won't somebody think about Apple?
Medicare approves new technology add-on payment for inpatient radiology AI solution
The federal insurance program for seniors will pay a maximum of $137.53 per case for Aidoc's CARE (Clinical AI Reasoning Engine) Multi-Triage CT Body tool.
Apple's Warnings About Spyware Are Real, Don't Ignore Them
"Mercenary spyware" isn't targeted at everybody, but don't skip the notification if you see it.
Trump’s Kennedy Center and ballroom fixations are political malpractice for the GOP
Republicans are facing a potentially ugly 2026 midterm election in less than three months. And nobody seems to be able — or perhaps even cares to try — to prevail upon President Donald Trump to mitigate the damage.
838-HP Aston Martin Valen Is A V12-Powered Monster With A Radical Carbon-Fiber Body
It's the most powerful front-engined Aston Martin in the company's history.
Where to Watch the Game: Tampa Bay’s Best Sports Bars
Anyone can watch the Buccaneers or Lightning from the couch, but nothing beats catching the game surrounded by fellow fans
Immune cells flood into the aging brain, Stanford scientists discover
Scientists have discovered that the aging human brain may be far less isolated from the rest of the body than once believed. Stanford researchers found that large numbers of immune cells from the blood begin entering the brain as early as middle age, where they can transform into microglia, the brain’s specialized immune cells. The finding overturns a long-standing assumption that these cells remain largely separate from the body’s immune system throughout life.
More Than Half of CEOs Say Local Governments Don't Support Business. That's a New Low
According to Inc. 5000 data, chief executives say local government isn't embodying a business-friendly mindset. Some experts attribute the shift to one key event.
I Wore an Electrical Muscle Stimulation Body Suit to Zap Myself Into Fitness
Can electrifying your workout offer a shortcut to a stronger, fitter you? I sweated in a skintight EMS suit for two months to find out.
Two Surprising Fruits That Boost Heart Health (Without Raising Blood Sugar)
Here's what researchers found when pairing avocado and mango
AI needs science’s search history
“Actually, that’s where the gold is,” said Alasdair Russell, my graduate school friend who leads a pre-clinical genome editing group at Cambridge. He was talking about the winding road of science that is omitted from published papers. “When you’re discussing how to do the experiment, and why this way is better than another way, and what does the data really mean? I know what it shows, but what does it mean?” At RAAIS 2026, he described how his group has begun logging the twisting path of discovery as it happens, recording the verbal and written exchanges that normally disappear. Ideas become nodes in a living graph: they branch when a meeting produces two plausible experiments, merge when separate lines of evidence converge, and go dark when someone quietly stops pursuing them. In his implementation, one agent scores novelty, while another tries to learn “how scientists think and how they navigate through a complex world of data,” so that high-potential nodes can trigger deeper investigation. As frontier AI labs deploy agents toward scientific discovery, giving AI authentic scientific taste remains a trillion-dollar dilemma. The bottleneck is that the record we have kept for centuries of science might be insufficient to get us there. The experiments that never make the paper Peter Medawar, 1960 Nobel laureate and “father of transplantation,” asked in 1963 whether the scientific paper was a fraud, and answered yes: the form of the paper misrepresents the thinking that produced it. Sixty years on, the diagnosis is unchanged. A paper presents a clean progression from hypothesis to result to conclusion. Lost along the way are the unconventional theories, the abandoned or unaffordable methods, and the underwhelming and inconclusive data. It reads like a browser history with every dead end deleted: the ten open tabs, the four rephrased queries, the wrong turn down a subforum. All scrubbed, leaving one clean path from question to answer as the canonical path. What has changed since then is that the discarded material is now worth something. No high-impact journal wants these artifacts, but raw trial and error is the most likely source of the training data required to develop scientific intuition, or what researchers call taste. Earlier attempts to capture the discards were motivated by scientific integrity. The Journal of Negative Results in Biomedicine launched in 2002 to publish rigorous studies that disputed established models or exposed ineffective treatments. Its archive preserved negative conclusions after they had become papers, rather than the live alternatives and arguments that produced them. BioMed Central closed it in 2017, saying the mission had been served now that other journals publish null results. A less generous reading is that in fifteen years it published around 200 papers because almost nobody wants to read a negative result, let alone write one up when it will not count toward academic tenure. AI models are different. Even an uninteresting negative result can be useful, provided it is labeled. Earlier this year, Anthropic put a version of this to the test. The company pulled 129 decision points from real Claude Code sessions between January and March 2026, showed models the work up to a human detour, and asked what should happen next. Claude Mythos Preview beat the human choice 64% of the time, while Opus 4.5 managed 51%. The comparison was tilted toward the models because Anthropic deliberately chose moments where the human decision had room for improvement. On 127 further scenarios where the human action was already strong, the models improved on it only about 20% of the time. The study was possible because Anthropic’s researchers work inside a tool that logs by default. The reasoning, detours and outcome are produced in the same working environment. Biology has no equivalent. Its reasoning happens in hallways, at benches, in Slack threads and on whiteboards, while the outcome arrives weeks later somewhere else. The record has to emerge from the work itself. Ask scientists to reconstruct it afterwards and we’ll create another polished account. Subscribe A log is not a label Before any of this becomes training data, a negative result has to say what failed. The first paper published in the Journal of Negative Results in Biomedicine examined 234 negative studies across five leading medical journals. Only 30% discussed statistical power, and half clearly defined a primary outcome. Tell a model an experiment failed, without telling it whether the assay was underpowered, a reagent had degraded, or the hypothesis was simply wrong, and it will learn noise with confidence. Decision histories have a second missing label too. When a lab considers five experiments and runs one, only the chosen branch returns an outcome. The other four are experimental counterfactuals. Researchers call this the selective labels problem: the data reveal results only for the actions someone chose to take. Such a record can teach a model to imitate a lab’s taste, but it cannot establish that the taste was good. It also smuggles local constraints into general lessons. A lab that never ran cryo-EM because it did not own a microscope teaches a model that cryo-EM is rarely the right call. Alasdair’s nodes preserve the candidate set, which is the necessary first step. To be useful, each decision record needs six fields: The evidence available at that moment, and nothing that arrived later. The candidates considered, including the ones dismissed in a sentence. For each candidate: the expected result, the confidence attached to it, and the cost in time and money. The route chosen, and the reason. What happened next. How the evidence changed the scientist’s view. These must be timestamped before the outcome, because hindsight turns uncertainty into inevitability. Disagreement also has to survive. Averaging three scientists into one clean rationale reproduces exactly the information loss we are trying to fix. But there is an obvious failure mode here. Once decisions are logged and scored, people log for the record post-facto. Anyone who has watched an electronic lab notebook fill up with retrospective tidying knows how quickly a research tool becomes a compliance exercise. A record that costs a scientist ten minutes of honest reflection per decision is worth far more than one that costs an hour of performance. A publication initiative called Registered Reports offers a useful starting point. Here, researchers submit their rationale, methods and analysis plan for peer review before the data exist, and the journal commits in principle to publish if they follow the approved plan. Nature has now expanded the format across every field it covers. This approach to paper writing timestamps intent before the outcome, but it freezes one plan. A useful search history must also preserve how the plan changed, which alternatives were rejected, when, and on what evidence. Subscribe Run the runner-up Autonomous labs show what happens when decisions and outcomes are connected in a loop. Liverpool’s mobile robotic chemist ran 688 experiments over eight days in a ten-variable formulation space. A batched Bayesian search used each result to choose the next experiments and found photocatalyst mixtures six times more active than the starting formulations. Every completed experiment changed what the system did next. The robot optimized within a goal and search space that humans had already chosen. It did not decide which scientific question mattered. So what this work demonstrates is narrower, but still useful: a search history pays off when the options return standardized outcomes quickly. Open-ended biology is harder because branches can take weeks and the discarded alternatives may never be run. Some exploration therefore has to be bought. Where two branches are plausible and the stakes justify the cost, a lab should sometimes run the runner-up. Otherwise the record captures what today’s scientists usually chose and stays silent on what they systematically overlooked. A funder could ring-fence a small fraction of a grant for the branch not taken, provided that the decision record and the outcome are both deposited. That costs money, but so does having every lab rediscover the same abandoned path. Test whether taste transfers When it comes time to evaluate if our new AI system exhibits taste, the comparison should run across laboratories and fields. At selected decision points in a live research campaign, we should freeze the six fields: the evidence, the candidates, expected results, confidence, costs and the choice made. Experts then rank the options before the outcomes are known, and those outcomes are checked independently later. We could give models one of two diets - papers alone, or papers plus decision histories - and ask them to rank the next experiment on unfamiliar projects. Then, we score information gained per dollar and week, calibration, and how quickly weak branches are abandoned. If histories improve choices only inside the lab that produced them, they amount to useful organizational memory. If they improve choices on unfamiliar problems elsewhere, Alasdair’s group will have captured something science has never managed to write down: a transferable record of taste. Until that happens, a scientific search history is a promising record, not yet a training set.
Twitch Admits ‘Nobody Would Opt-In’ To AI Training, Here’s How To Opt-Out
Twitch streamers were surprised this week to discover that their streams and content were being used to train Amazon AI models.
Twitch is training AI on livestreams, says it's an opt out feature as "nobody would opt in"
The chief product officer offered the cold hard truth behind a controversial new addition to the live stream platform.
'Imposing ignorance': US climate science under siege
A benchmark U.S. report on the fast-changing state of the Arctic has been canceled. The nation's top research body has removed a chapter on global warming from a reference manual for judges.
Rams star names 49ers nightmare he ‘hates’ facing
“There’s nobody that covers that much space,” Nacua said. “It’s scary. The middle of the field is terrible.”
Amazon will train on Twitch streamers' content by default, unless they opt out
"If this was opt-in, nobody would opt in," Twitch CPO Mike Minton said on a livestream responding to user feedback. "That's honestly the answer."
Astronomers discover a new kind of cosmic object
The body is the size of the entire solar system and glows with a brilliant red light about 30bn light years from Earth
UT Health San Antonio study reveals how the liver’s internal clock may influence metabolism
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, Aug. 12, 2026 — What if one of the keys to a healthier metabolism is understanding how and when the liver communicates with the rest of the body? Researchers at UT Health San Antonio, the academic health center of The University of Texas at […]
New 'magnetoelastic' tent generates electricity from wind, body movement and sound to power small devices
A magnetoelastic tent concept could one day turn wind, movement and fabric flexing into usable electricity.
GUARDIANS NEWS: NOBODY HAS EVER BEEN LESS CLUTCH
No group of humans has ever been less clutch than the 2026 Guardians. Matt Underwood and Chris Gimenez are the dumbest humans to ever share a big league broadcast booth, but even they noticed that Guardian hitters refuse to take any pitches when there is a runner in scoring position. These hitters have a coach. […]
Philadelphia Eagles QB Predicted To Get Traded Before Final Cuts
The Philadelphia Eagles have a quarterback controversy, but it’s not on a major scale. Jalen Hurts is the guaranteed starter. His backup? That’s between Andy Dalton and Tanner McKee. Before the final week of the 2025 NFL regular season, nobody could’ve predicted that McKee would be seen as somebody on the chopping block, yet here […] The post Philadelphia Eagles QB Predicted To Get Traded Before Final Cuts appeared first on HEAVY.
Jenna Ortega would go ‘all day without eating or drinking’ as a kid on set to ‘not be in the way’
Jenna Ortega was so desperate to ‘not be in the way of anybody’ on set when she was a child actor that she would ‘go all day without eating or drinking.’
Radiologists criticize noted neuroscientist podcaster’s claims supporting whole-body MRI
Andrew D. Huberman, PhD, a professor of neurobiology and ophthalmology at Stanford Medicine, voiced support for these scans in a recent social media post.
Psychopathic Tendencies Are Linked to Microbes Inside Your Body, Study Reveals
It’s not just you.
The Marisen GT Is the Latest Wild Porsche 911 Turbo S-Based Supercar from Marc Phillip Gemballa
Marc Philipp Gemballa’s latest 911 build gets carbon bodywork, RUF-assisted upgrades, and more than 830 hp.
Top Science Body Deletes Climate Chapter From Judges’ Manual
The National Academies of Sciences, Engineering and Medicine had been under pressure from Republican leaders, including President Trump.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
Tupac murder trial witnesses include Suge Knight, Diddy bodyguard
The official witness list for Duane Keith "Keffe D" Davis' looming trial over the 1996 shooting death of hip-hop superstar Tupac Shakur has been released.
Pain, stigma and barriers to care: The burden of cysts and fibroids in Africa
As a teenager in Kenya, long before Evelyn Okinyi Owala became a professional bodybuilder, she attended school, spent time with friends and helped her parents around the house. But during her period each month, she said, she experienced excruciating pain, vomiting, fever, lightheadedness, heavy bleeding, pelvic pain and acne.
Microplastics Are Part Of Everyday Life. What Does That Mean For Our Health?
What do microplastics mean for our health? Scientists are finding them throughout the human body as research raises new questions about everyday exposure over time.
Minimal Phone 2: first look reveals an OLED display, improved QWERTY keyboard, and 5G support
The Minimal Phone 2 has appeared in an official teaser video that shows off its new design and a couple of features. The compact phone still sports a QWERTY keyboard but now has an OLED display and an aluminum body.
Frequent cannabis users wake up with their “stress hormone” already elevated
Frequent cannabis users may wake up with unusually high levels of the stress hormone cortisol, suggesting their daily stress rhythms could be disrupted. Researchers say the finding raises questions about whether using cannabis for stress relief might, over time, interfere with the very system that helps the body handle stress.
For decades, we were told to choose low-fat dairy. New research says otherwise
Full-fat dairy may be healthier than conventional advice has suggested. In a 12-week study, adults who ate three servings a day showed no meaningful increases in weight, body fat, cholesterol, or insulin resistance. They also experienced improved blood pressure and consumed more calcium, protein, and vitamin D. The findings suggest dairy’s complex structure may matter more than its saturated fat content alone.
‘Everybody can’t leave’: East Carroll Parish’s health lags behind, but community finds hope
"People want to have quick answers ... but there isn't just one simple solution to make it go away."
'It's everybody that's under this cloud of smoke': The mental health impact of the Spokane Complex fires
From a psychological standpoint, Spokane is in shock.
Top 10 Most Hated Fanbases in College Football
College football wouldn’t be college football without obnoxious fanbases. Every program has great fans, but some groups have developed reputations that make the rest of the country absolutely hate them. Here are my 10 most hated fanbases in college football. 1. Tennessee — All the Confidence, Not Enough Hardware Nobody becomes more confident after a…
Seahawks' Jadarian Price: Dealing with lower-body soreness
Seahawks' Jadarian Price: Dealing with lower-body soreness
Joe Biden’s prostate cancer getting worse, Hunter Biden says
Former US President Joe Biden’s prostate cancer has spread to other parts of his body and is causing him pain, even as he continues to speak out on public issues, his son Hunter said in an interview.
Cutting sweet foods doesn’t curb cravings or improve health
Changing how much sweet-tasting food people eat may not change how much they crave or enjoy sweetness after all. In a six-month trial, researchers found that people assigned to high-, low-, or average-sweetness diets showed no meaningful differences in their preference for sweet foods, body weight, or markers linked to diabetes and heart disease. Many participants also drifted back toward their previous eating habits once the trial ended.
Cutting sweet foods doesn’t curb cravings or improve health
Changing how much sweet-tasting food people eat may not change how much they crave or enjoy sweetness after all. In a six-month trial, researchers found that people assigned to high-, low-, or average-sweetness diets showed no meaningful differences in their preference for sweet foods, body weight, or markers linked to diabetes and heart disease. Many participants also drifted back toward their previous eating habits once the trial ended.
Browns Add 293-Pound Ex-UFL Standout to Mix
The Cleveland Browns have added another big body to their defensive line. The post Browns Add 293-Pound Ex-UFL Standout to Mix appeared first on HEAVY.
Full body MOTs - the future of healthcare or a headache for the NHS?
The private body scan industry is booming, but is it doing more harm than good?
What watching sports does to your mind and body, according to scientists
Scientists find watching sports raises fans’ heart rates, spikes cortisol, and may even affect cardiovascular health – but researchers say the social benefits can outweigh the risks. From World Cup fever to the Knicks’ title run to a new NFL season, NBC News' Dr. Akshay Syal looks at what cheering on your favorite team does to your body.
These 'five pillars' for living healthier longer are easy and affordable
Longevity has become a bit of a buzz word, and has become increasingly aligned with the tech industry. But while it remains unclear whether the billions of US dollars being invested in life-extending bioscience is something any of us can access, a timely report from Harvard Medical School reminds us what we can do on our own – and it's backed by a huge body of evidence.
ICE body camera video release policy
After years of delays, ICE said its field officers nationwide will have body-worn cameras by the end of September.
After Myles Garrett trade, Jared Verse confident joining Browns: ‘I’m ready to see the look on everybody’s face’
Scientists find unexpected life on Ötzi the Iceman’s 5,300-year-old body
More than 5,000 years after his death, Ötzi the Iceman is still hosting a remarkable mix of ancient and modern microorganisms. Researchers separated microbes that lived in his body during his lifetime from those that arrived after his death, uncovering traces of his original gut bacteria and cold-loving yeasts that may have survived alongside him in the glacier for millennia.
Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate
Encapsulated IL-10–producing cells locally suppress fibrosis and extend graft function in rodent models and a nonhuman primate.
A hidden conversation inside injured tissue may hold clues to regeneration
When tissue is damaged, healing isn't simply a matter of growing new cells. The body also has to know when to stop growing and begin rebuilding. If those steps happen out of order, the tissue may never fully recover.Researchers, led by Arizona State University Associate Professor Rob Harris, have discovered what appears to be a previously unrecognized communication system that helps coordinate those two stages of repair.
VA accelerates electronic health record rollout
After years of delays, the Department of Veterans Affairs says its federal electronic health record (EHR) program is now firmly back on track. VA Secretary Douglas Collins has accelerated the program with a renewed goal: full deployment across all VA medical centers by 2031. A major governance overhaul, replacing multiple competing councils with a single decision-making body, has cut through bureaucratic delays and allowed the VA to move faster and more consistently. Deputy Secretary Paul Lawrence has taken a hands-on role, including visiting deployment sites and holding daily meetings with Oracle Health to ensure front-line clinicians have what they need. Here’s how the rollout is going, according to the VA: The federal EHR has only experienced four outages since December 2025. The system has gone nearly two consecutive years without a major incident. It is currently live at six sites, supporting care for over 188,000 veterans. The system creates a lifelong medical record, integrating data across the VA, the Department of Defense and private community providers. With the first new deployments underway and four Michigan medical centers already live in 2026, the VA is entering its first true expansion phase since the program’s reset. Officials say the system’s improved stability, streamlined governance and standardized national workflows have cleared the obstacles that once stalled progress. With 13 sites scheduled for deployment in 2026 and a market‑based rollout strategy guiding future waves, the department believes it’s finally positioned to move at scale toward a modern, fully interoperable EHR, advancing steadily toward its goal of reaching every VA medical center in five years.
Butterfly lilies wing their way to Science
Many animals and plants show left-right differences in how their bodies or organs are arranged, but we still know little about how such asymmetries evolve or how genes control them in natural populations. Mirror-image flowers, in which female and male sex organs are deflected to opposite sides in left- and right-handed forms, provide a notable example of such asymmetry. Here, we studied South African butterfly lilies, where individual plants produce only left- or right-handed flowers. Their mirror-image flowers promote outcrossing by depositing pollen from each floral form onto a specific region of a pollinator’s body that matches the stigma position of the opposite form. This suggests that selection for efficient pollen transfer between forms maintains this natural polymorphism. Our work uncovers a hemizygous supergene that coordinates the left-right orientation of female and male sex organs in mirror-image flowers by linking two independently acting genes for style and stamen handedness in a single, nonrecombining genomic segment. This architecture ensures the coinheritance of a matched pair of organ orientations that is essential for efficient cross-pollination between floral forms. At the developmental level, we show that floral handedness emerges from the interaction between an intrinsic tissue chirality and a gravitropic response that orients the style and median stamen relative to gravity. Together, these findings reveal how a supergene, hormone and microRNA signaling, tissue chirality, and an external physical cue combine to produce and maintain a stable left-right polymorphism in natural plant populations.
Crystal made from 13-sided 'einstein' shape bends light in ways nobody imagined
Scientists carved a 13-sided shape called an "einstein" into a chip and discovered that it steers light in ways no other crystal does.
Crystal made from 13-sided 'einstein' shape bends light in ways nobody imagined
Scientists carved a 13-sided shape called an "einstein" into a chip and discovered that it steers light in ways no other crystal does.
Travis Kelce’s coach Andy Reid defends athlete from ‘dad body’ claims in wake of Taylor Swift wedding
Travis Kelce’s coach Andy Reid defended the tight end from ‘dad body’ claims weeks after marrying Taylor Swift.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Gotham FC, Flamingo and the Women's Sports Foundation® Announce Built to Move, A New Study Linking Movement to Greater Body Appreciation
JERSEY CITY, N.J. (Aug. 5, 2026) – Gotham FC, Flamingo and the Women’s Sports Foundation (WSF®) announced Wednesday the findings of new research exploring the relationship between physical activity an
He posted about this controversial medical test. Then came the backlash
Andrew Huberman's recent comments about full-body MRIs sparked a new wave of controversy. Here's what happened.
He posted about this controversial medical test. Then came the backlash
Andrew Huberman's recent comments about full-body MRIs sparked a new wave of controversy. Here's what happened.
567-million-year-old fossils rewrite the dawn of animal life
A spectacular fossil site in Canada contains 567-million-year-old creatures that may represent some of the earliest animals to move, reproduce sexually, and develop recognizable body plans. The discovery pushes key evolutionary milestones back by up to 10 million years and suggests complex animal life may have first flourished in the deep ocean.
A colossal magma system has been hiding beneath Tuscany
A massive magma reservoir has been detected deep beneath Tuscany, despite showing no obvious signs at the surface. Scientists mapped the roughly 6,000-cubic-kilometer body using natural ground vibrations recorded by dozens of seismic sensors. It poses no immediate danger, but the discovery reveals how enormous volcanic systems can remain hidden and could transform the search for geothermal energy and critical minerals.
Ariana Grande’s body is in the news again
The pop star’s body is back in the news as she announces a break from public appearances.
Amid trend in health optimization, Berkeley scientists focus on brain optimization
What’s a healthy body without a healthy brain? Neurologists, neuroscientists and psychologists unite to find metrics for brain health and effective training to improve it.
If Not AOC, Then Who?
What do we do if Alexandria Ocasio-Cortez decides not to run for president in 2028? It makes sense that many leftists are currently focused on calling on her to take the plunge. But the absence of a Plan B, or even much discussion about one, is worrisome. The US Left can’t afford to sit out the 2028 Democratic primary. Doing so in 2024 was a disaster: our abstention self-marginalized anti-billionaire politics from the national conversation and thereby gave space for Harris to pivot to the “center” (i.e. the policy preferences of corporate donors, establishment hacks, and AIPAC). Abstaining again in 2028 would be especially counterproductive since democratic socialists now have so much wind in our sails after our big electoral wins in NYC and across the country. It’s time to deepen our momentum, organization, and profile — not to retreat to the margins during America’s single most important political battle. Even more urgently, keeping Trump’s heir out of the White House may depend on whether leftists and the party’s unprecedentedly disenchanted base can force the Democrats in 2028 to take meaningful steps towards a very angry electorate and away from the corporate-consultant blob that has helped get us into this mess. If AOC (or Abdul El-Sayed) decides to run, we should enthusiastically go all in — DSA, fighting unions, progressive organizations, anybody who wants to see a better country and world. But, as far as I can tell from the outside, there’s a real chance that she doesn’t run. And we can’t just wait and see where she lands before discussing alternatives, since AOC’s decision might not come for quite a while, giving us little time to scramble at the last minute for an alternative. So we should start working now on getting a Plan B into motion, and recruiting a good candidate for the role. Here’s one idea. A Worker Candidate — Healthcare Not Warfare 2028 Run a union worker Leftists don’t need to always run experienced, well-known socialist politicians for high-profile contests. Lula, the current president of Brazil, began his political career as a metalworker militant who ran for governor of São Paulo in 1982. Especially in an era of institutional distrust, it’s possible to lean hard into making a virtue out of a working-class comrade’s distance from traditional politics. Experience abroad shows this clearly. Rachel Kéké — an immigrant hotel housekeeper — ran as the candidate of the leftist La France Insoumise for the National Assembly in 2022, defeating a former minister in the Macron government. The Belgian Workers’ Party in 2024 won its first Flemish seat in the European Parliament by running Rudi Kennes, a three-decade veteran of the Opel Antwerp auto factory. And the South Korean left in 2024 elected auto factory militant Yoon Jong-oh to the National Assembly. If a tiny French Trotskyist organization could make such a big splash in 2002 and 2007 by running a well-spoken postal worker cadre for office — the LCR’s Olivier Besancenot received about 1.5 million first-round votes — it’s not far-fetched to expect that a much larger organization like DSA, together with a broader coalition of the willing, could run this playbook to much greater effect. This is especially the case now that almost everything DSA does immediately becomes a national news story. We don’t need someone famous. We just need a charismatic, well-vetted comrade who works in a relatable working-class occupation — e.g. a nurse, or a worker in auto or construction, or at Amazon. Ideally, they have a compelling personal story or have been part of a significant strike or organizing campaign, but even those criteria don’t necessarily have to be deal-breakers. The main lesson of the Graham Platner fiasco isn’t that we should never run outsiders for office (the momentum he generated proves the exact opposite), but that they need proper vetting and roots in democratic membership organizations like DSA or a union. In any case, there are plenty of ways to signal working-class authenticity without resorting to Platner’s or Fetterman’s performative macho white dude affect. Better to have someone of any gender or race who is actually working class, with firm socialist politics, who can speak from experience about the day-to-day realities of trying to make it in America. There are surely at least a dozen such worker leaders in our movement nationwide; we just need to sit down and convince one that their personal sacrifice for the greater good (i.e. running for president) will be worth it. If we don’t have a frontrunner with a clear path to victory like AOC (or El-Sayed, were he to win Michigan), it’s better to embrace someone whose decision to run in itself tells an important story about US politics: workers have been iced out of our political system and are now fighting hard to break back in. The novelty factor, in itself, would generate press. And it would help democratic socialists signal to the American public that our movement’s defining characteristic is that we represent workers vs. bosses, not that we’re “the furthest left” force in American politics — a framework that suggests we’re extremists and that helps our opponents isolate us from non-college-educated voters by highlighting extremely minoritarian (and misguided) stances included in DSA’s platform like prison abolition. We don’t get many opportunities to speak to tens of millions of Americans; we need to use these opportunities to broaden our appeal beyond those already in our orbit. Run to polarize the 2028 primary and general election around “Medicare for All” and “End All Aid to Israel” Why should democratic socialists use our scarce time and volunteer energy to run in a race we’re unlikely to win? Running in the 2028 primary will not only recruit us scores of members (imagine having a DSA member intervening in eleven nationally televised primary debates!), but — more importantly — it has the potential to be a decisive leap forward towards an America that finally starts meeting the needs of working people instead of HMO and AIPAC billionaire donors. Polarizing litmus tests are good, actually — as long as they’re fought for around popular demands in a thoughtful and strategic way. Democratic socialists have an opportunity and responsibility to make the 2028 primary about two of the most widely and deeply felt issues of our moment: domestically, America’s unaffordable, family-breaking private healthcare system; internationally, America’s bankrolling of the genocidal Israeli government. A candidacy relentlessly demanding Medicare for All and No Aid to Israel would pose a sharp question to the American public, the Democratic Party, and other 2028 contenders: Why can’t working-class Americans afford their healthcare bills at the same time that our government is spending at least $3.8 billion yearly to fund an Israeli regime eager to keep dragging us and the world into more forever wars? Our candidate can agitate around a clear message: I’m running to give voice to all those working-class Americans who are struggling to get by. No matter what state you live in, who you voted for in 2024, or your background, it’s just plain common sense that we should make healthcare more affordable instead of spending billions to enable the Israeli government’s crimes against humanity. Every American who agrees with me when I say ‘Medicare for All — Not a Dime for Israel’ should make their voice heard through our campaign. Racking up a high number of votes for this agenda is a crucial way to show the Democratic Party and the country as a whole that we can’t keep supporting a life-destroying status quo in our healthcare system and in the Middle East. If we want to defeat Trump’s handpicked crony this coming November, we need to speak to ordinary people’s frustrations with the status quo — we can’t keep running the same tired establishment playbook and expecting a different result. For those highly engaged voters (or skeptical media pundits) who raise concerns about wasting votes, the candidate can take the time to explain why this isn’t the case: It's true I'm a long shot. But Zohran showed anything can happen — and voting for me is a pragmatic decision, not a wasted vote. In a heavily divided primary with a large number of candidates and a very discredited establishment, my campaign and the democratic socialist movement I’m part of are positioned to be the balance of power if we can get a large enough number of voters to loudly demand Healthcare Not Warfare. Since there’s a high chance no candidate will get to 50% in the 2028 primaries, the Democrats could very well be heading towards a brokered convention, where a disciplined, principled current committed to breaking from corporate donors can play an outsized role in making sure whoever ends up with the nomination raises the banner of single-payer healthcare and cutting aid to Israel. How exactly could running this sort of primary campaign be translated into actual leverage? The candidate replies: I’m aiming to win the nomination, but if I don’t achieve that goal, my delegates and I will pledge our support in the primary only for a candidate who agrees in the general election to call for ending US aid to Israel and establishing Medicare for All at home. These are both winning planks for November against the Republicans, and the only reason I can see that other candidates haven’t yet raised these is that they’re still more scared of the donor class than they are of the people. That needs to change. If Democratic leaders want young people, workers, and those sick of the status quo to show up in big numbers this November, they need to meet us halfway. In this way, whether or not we win the nomination, democratic socialists could still play a decisive role in 2028. The approach outlined here is similar to what radical left parties periodically do in parliamentary democracies like Denmark or Sweden when they find themselves as a junior partner electorally: they dictate to center-left allies what their terms would be for enabling, from the outside, the formation of a new government. Running a Healthcare Not Warfare candidate will make it significantly more likely that the 2028 Democratic candidate stands with ordinary people instead of donors on these two pivotal planks — a shift that will, in turn, make it easier to achieve the existentially important task of defeating MAGA’s heir in November. Look at how much popular traction the Uncommitted movement got with a similar strategy in 2024 with so little on-the-ground organization — surely we can go much further with a working-class candidate, a much bigger DSA, and a Democratic Party base that has turned against Israel, billionaires, and the hacks in the party who prop them up. Objections and Responses There are quite a few objections to this proposal, many of which are very reasonable. Let me briefly address each here. Socialists shouldn’t waste their scarce time and resources on a candidate unlikely to win. This is a good rule in general, but there are important exceptions, and presidential elections are the main one. There’s no other political contest that gets anything like this level of attention and engagement in the US, so if you want to be a serious force in nationwide politics, you basically can’t afford not to have a candidate. Far from being an overall drain on our resources, running a dynamic 2028 campaign would likely result in a major net increase in members and capacity. In that spirit, the very pragmatic Milwaukee sewer socialists — who mostly ran to win at home in Wisconsin — supported Eugene Debs’s propagandistic presidential campaigns, which they correctly saw as a crucial means of recruiting to the Socialist Party. And now that the (post-1972) Democratic Party gives more weight to voters than party operatives in determining its presidential nomination, it’s become feasible to run as a socialist in primaries without risking a split in the vote against the Republicans in November. We should just support Ro Khanna, who also supports M4A and ending aid to Israel. I like Ro Khanna and would enthusiastically vote and canvass for him for president were he to get the nomination. But there’s a real chance that Khanna’s bid for office doesn’t catch on; he lacks the grassroots organizational apparatus of DSA, and, because he’s not really of the Left or labor (despite his current very good positions), he’s unlikely to generate the type of buy-in and enthusiasm that a DSA candidate would. Moreover, Khanna would be running as an individual, not as someone emerging from and building an organized movement — his campaign would not likely focus on building sustained power from below, nor would it likely polarize the 2028 primary around M4A and Israel aid. Also, and not inconsequentially, the poor electoral results for Tom Steyer and Saikat Chakrabarti this spring suggest that there’s perhaps not much of a popular appetite in the Democrats’ base to support multi-millionaire class traitors. Much better, then, to run a democratic socialist worker. If by Super Tuesday it’s clear that our campaign has captured the main left lane in the primary, Khanna should drop out and endorse us; conversely, if he’s managed to capture this lane, DSA could at that point transform its Healthcare Not Warfare campaign into an independent campaign to elect Ro Khanna focused on winning (and holding him accountable to) those two critical planks. An openness to consolidating an anti-corporate candidate by Super Tuesday is a necessary component of the strategy I’m proposing, because otherwise we risk splitting the primary votes (per DNC rules, you need at least 15% to get any delegates to convention). We should convince Shawn Fain or Sara Nelson to run for president instead. I agree it’d be great if either ran for president, but my impression is that there’s basically no chance that will happen in 2028, because both are firmly focused on their union leadership duties (and, in the case of Fain, beating back a federal witch-hunt). This plan could have DSA end up endorsing a non-socialist, non-DSAer for president. That’s against our principles. It’s a myth, and bad politics, that socialists can’t ever support candidates who aren’t members of their organization and/or who don’t call themselves socialists. Bernie, after all, was not a DSAer. And socialists abroad regularly make tactical decisions about if and when supporting a non-socialist candidate makes sense from the standpoint of promoting working-class interests, defending democracy, and building a socialist current in the process. If your “principles” prevent you and DSA from helping achieve the momentous stride forward of having a Democratic candidate in 2028 run on Medicare for All and ending aid to Israel, those “principles” are not very good. In fact, they actively undermine the causes they’re aiming to support. We shouldn’t confuse principles (working-class independence) with tactics (the best way to advance this in a given context). In my recent article in Catalyst on Milwaukee sewer socialism (I’ve uploaded the full text here), I have a section showing how similarly rigid rules about endorsements had to be eventually discarded in the old Socialist Party nationwide after WWI because they tended to lead socialists towards a sectarian abstention from broader anti-corporate electoral insurgencies beyond their party’s control. For what it’s worth, Lenin’s current under Tsarism frequently backed bourgeois candidates in the second round of elections and Lenin himself advocated that British Communists support Labour Party candidates; for his part, Kautsky in 1912 defended the German Social Democracy’s electoral pact with the Progressives in the runoffs. If our predecessors could be that tactically flexible in an era before the limits of their underlying strategic assumptions about intransigent class politics in capitalist democracies were made clear, then there’s no need to insist on being more tactically rigid today, after a century’s worth of accumulated experience. As long as you maintain your own political profile and organization while engaging in broader coalitional efforts, there’s zero inherent contradiction with the principle of political independence. More specifically: DSA and allied organizations should enthusiastically back Michigan’s Abdul El-Sayed if AOC declines to run and he throws his hat in the presidential ring. (I have no idea whether he’s even considering this path, but there’ll surely be chatter about it if he wins his Senate race this November.) Though he doesn’t call himself a socialist, El-Sayed is a principled Berniecrat, a consistent fighter for Palestine, and would have a clear path to victory. Using the “s” word is far less important than whether a campaign fights for the interests of working people at home and abroad — and whether actively participating in it can grow the organized working class and the Left. And the same holds true if a less anti-corporate candidate were, under pressure, to adopt our two Healthcare Not Warfare planks. Why focus only on M4A and ending US aid to Israel? There are so many other important issues to fight for! Obviously there are many pivotal issues beyond healthcare and Israel, and our candidate — and especially our organizations involved in the campaign — should be prepared to speak on all of these. But one of the crucial lessons of the Zohran campaign is that you have to relentlessly stay on message if you want to cut through the noise. CNN and Fox News will want to talk about DSA’s views on Venezuela and abolishing the police; we need to polarize the debate on the widely and deeply felt issues that are most favorable for growing the Left, isolating our opponents, and winning urgently needed changes. One recent poll found 63% of Americans support M4A, even after respondents were told it would raise taxes and eliminate most private insurance. Another found that 74% of Democrats opposed “providing additional economic and military support to Israel.” And focusing on two demands sets the campaign up to be able to leverage its mandate to make clear demands upon other candidates (which we can’t do if we run with a laundry list of demands). Talking about a Plan B is a distraction from the more urgent work of building a groundswell of calls on AOC to run. It’s good for DSAers, fightback unionists, and progressive organizations to try to convince AOC to run. This proposal is meant as an addendum to pushes to get AOC to run and to line DSA up for that eventuality, not as a substitute for those efforts. But I’m worried that, like in 2024, we might eventually find ourselves with no time to find a viable alternative unless we start now. DSA, with its abundant deliberative processes, moves slowly. The approach you’re suggesting seems risky. If a DSA candidate runs but doesn’t receive a lot of votes, it’ll undercut our current national momentum. This is a reasonable worry. All big initiatives always carry risks, and the path I’m advocating is certainly not free of these. That said, if a Healthcare Not Warfare campaign doesn’t catch on like we envisioned, it’s a pretty simple pivot in March 2028 to explain that in the future we really need our standard-bearers like AOC, or our growing bench of national electeds, to step up in presidential primaries. Moreover, it’s worth noting that the risk of my Plan B proposal is on the whole significantly less than the risk entailed by an AOC run. We should all back her if she runs, since she’d fire up the base, provide huge openings for organizing, have a real shot at defeating a Republican (especially given MAGA’s unpopularity), be a great standard-bearer for our issues, particularly M4A and ending aid to Israel, and be less willing than mainstream candidates to capitulate to any anti-democratic machinations from Trump and co. But it’s also true that AOC could lose, which would be a devastating setback to the country and the Left. Or she could win and find herself unable to pass much, if any, of her (and our) program, a demoralizing prospect. So if we’re willing to take these risks with AOC (and we should), it follows that we should be able to take lower-level risks if she doesn’t throw her hat in the ring. What’s Your Plan B? The US Left is facing its biggest opening for growth and influence since the 1930s. Initiatives that would have been impossible a few months ago are now potentially feasible. A President AOC is now easier to imagine, but if she ultimately assesses that the risks aren’t worth the potential reward in 2028, we can’t be left flat-footed. So even if you’re not convinced by the specifics of my Plan B, I hope you can at least agree that it’d be a disaster for us not to have one — and not to start getting a Plan B into motion. Hopefully other organizers and political currents will put forward their responses and alternative ideas ASAP. The stakes are too high to just wait and see. More As always, please share this article widely. This newsletter depends on all you lovely people to get the word out. Thank you! I uploaded the full text of my Catalyst article on Milwaukee sewer socialism here (it’s updated and 3x as long as the version published earlier on this substack). If you haven’t yet, please make sure to subscribe to Catalyst here; I read every issue front to back, highly recommend. 🌹🎵 Ivan Lins (arranged by Arthur Verocai) — “General da Banda” 🌹🎵
Ariana Grande and when the cruel body commentary goes too far
Ariana Grande is stepping out of the limelight after public scrutiny on her health. How we respond matters.
How Friendships Can Benefit the Health of Your Mind and Body
Strong friendships have many benefits for the mind and body, including reducing the risk of chronic illness, so board-certified psychiatrist and author Sue Varma stops by TODAY to share her expert tips for making friends. She explains that it can take “50 hours to make a regular, casual friend” and up to “200 hours to make a bestie,” so she recommends showing up to places consistently, making small plans, being vulnerable, and focusing on “being interested versus interesting.”
How to Train, Fuel, and Recover, According to Science
I've spent 17 years writing about how the human body builds fitness, and I distilled the most important lessons into a new ten-part email series. Read the first installment below, and sign up today to get the rest delivered directly to your inbox.
Help your body fight inflammation through diet, meal timing
Does eating lighter at night help your body long-term? A Sanford Health dietitian explains this and other anti-inflammatory food claims.
These bizarre new beetles look so stretchy scientists named them Luffy
Scientists have named a newly discovered beetle genus Luffy, inspired by the stretchy hero of the manga and anime One Piece. The insects have unusually long, slender mandibles, antennae, and mouthparts that resemble Luffy’s rubber-like ability to extend his body.
Concert to benefit Everybody Eats
Flash in the Pans, a renowned Blue Hill community steel drum band, will hold a donation-based concert in Knowlton Park in Ellsworth on Monday, Aug. 10, from 7:30-9 p.m.
Forget the gym: A 30-second test may be one of the best indicators of longevity
A certified personal trainer reveals the benchmarks for the 30-second chair stand test and exercises that can improve lower body strength and fall risk.
Adults over 60 should try one 30-second test to predict healthy aging, experts say
Nick Schofield, a tactical athlete physical coach in the U.K., demonstrates how to perform the sit-to-stand exercise, which can be an indicator of lower-body strength and is closely linked to mobility, functional fitness and healthy aging.
Ariana Grande Says She’s ‘Taking A Step Back From Visibility’
The singer and actress has faced backlash and concerns for her body image in the last few years.
Juliette Lewis apologized to audience after “Cape Fear ”screening: ‘It was so disturbing’
The actress also said it was “very difficult” to keep her surprise appearance on Apple TV’s new “Cape Fear” a surprise: “Hopefully nobody guessed it was me.”
The Vikings’ Starting Lineup as Training Camp Gets Rolling
The Vikings’ starting lineup isn’t set in stone. That being said, there are many details that are already known. Nobody […]
This once-a-week workout may help cut belly fat, study shows
A surprisingly small dose of exercise may deliver major health benefits for adults carrying excess fat around the waist. In a four-month trial involving 315 adults with central obesity, researchers found that completing 75 minutes of brisk interval walking in a single weekly session reduced body fat, trimmed waistlines, and improved cardiovascular fitness about as effectively as splitting the same exercise across three days.
Guarding our health is an act of Jewish responsibility
Neglecting the body is not an expression of faith. Exercise, proper rest, and healthy habits are part of the Jewish obligation to protect the life entrusted to us.
Why an electric fan can make you hotter in extreme heat — and what to do instead
The CDC warns that electric fans can actually raise your body temperature in extreme heat. Learn the safe temperature limits and expert-backed ways to beat the heat.
How scientists are trying to repair the body from within: Regenerative medicine and anti-aging
At Scripps Research and its drug discovery arm, the Calibr-Skaggs Institute for Innovative Medicines, scientists are developing regenerative medicine therapies designed to help the body repair itself from within. Unlike traditional medicines that primarily manage symptoms or slow disease progression, regenerative medicine aims to restore damaged tissues and rebuild function lost to aging and disease. Researchers are advancing programs focused on the heart, lungs, digestive tract and eyes, including investigational therapies for heart failure, idiopathic pulmonary fibrosis, inflammatory bowel disease, age-related macular degeneration and other chronic conditions that become more common as we age. Learn how scientists are activating the body’s natural repair mechanisms to explore a future where medicine may not only treat disease, but help reverse its damage.
Kristen Beavers receives prestigious National Institutes of Health grant
With a passion for advancing healthy aging, Professor Kristen Beavers recently received a five-year National Institutes of Health (NIH) grant totaling more than $800,000 to enhance research and educational capacity in emerging areas related to aging, obesity, and body composition at Wake Forest University. This [...]
Study suggests eating less protein could be key to healthy aging for most adults
A new review has found that eating less protein, or less of certain amino acids that make up protein, may turn on body processes linked to healthier aging and metabolism.
Video: Opinion | A Doctor Weighs In on the Health Tracking Craze
If a fitness enthusiast like Joe Rogan wants to scan his body ad nauseam to track his wellness, that’s fine, says Dr. Rachael Bedard on “The Opinions.” But using those scans to look for medical abnormalities can lead to costly, potentially harmful follow-up tests.
FIFA insists 'nobody is selling football' after UEFA threatens to boycott tournaments if plans to sell off stake in World Cup go ahead
FIFA: Nobody is selling football. This is not something FIFA would ever entertain; UEFA reacted furiously to FIFA plan to seek private investment in competitions including World Cup; FIFA president Gianni Infantino has publicly backed the plan
Can bodies acclimate to 115-degree heat? A doctor breaks down the science
Residents spending time outside in July say they have gotten used to triple-digit heat, but medical experts warn that heat acclimation only protects the body to a point.
Harris County: Body found behind business on FM 1960
Authorities are investigating after a body was found behind a business in Harris County on Thursday evening.
Google DeepMind’s new AI model can control a robot’s entire body
The new model can help robots tie up trash bags and unscrew lightbulbs, too.
A unique antibody system may help explain bats' unusual tolerance of viruses
Researchers found that vesper bats use two separate sets of genes to build antibodies — a rare evolutionary quirk that may give them different ways to fight infection.
Origami-inspired sensor could continuously monitor our vital signs
A tiny sensor that unfolds within the body could continuously monitor our heart activity and breathing after showing promise in rats
Inflammation may trigger persistent 'out-of-body' experiences, emerging research hints
Researchers are investigating whether immune dysfunction can help explain dissociative disorders.
Your body vs. wildfire smoke. As Boise breathes bad air, it’s a fight for good health
The negative health effects of inhaled wildfire smoke can be many, as people’s lungs and oxygen delivery in the blood can suffer.
Digital habits that rob attention and energy — and how to combat them
There's a reason why double- or triple-screening your devices makes you feel tired, says NPR's Manoush Zomorodi. She explains the science of information overload and how to reclaim calm and focus.
Scientists Discovered ‘Zombies’ With ‘Immortal’ Body Parts. This Could Redefine What We Think Life Is.
A “gray zone” form of living could help scientists answer long-held questions about regeneration, aging, and how tissues survive under tough conditions.
Zombie sea cucumbers and the future of tissue engineering | Investors Lab
It's pretty cool, but not exactly news, that lizards can regrow their tails and starfish can regenerate arms. However, the lost or discarded body parts typically decay and die within a few days or weeks. Not so for those of at least one kind of sea cucumber. Researchers have found that detached tissue from these marine invertebrates can remain alive independently for years. Their findings could have a real impact on how we understand tissue culture, regeneration and aging in medical science. Saugat Bolakhe takes us beneath the surface for SN.